Use of metabolic markers to identify overweight individuals who are insulin resistant.
about
Insulin and insulin resistance.Role of a critical visceral adipose tissue threshold (CVATT) in metabolic syndrome: implications for controlling dietary carbohydrates: a reviewGold Nanoparticles in Single-Cell Analysis for Surface Enhanced Raman ScatteringTreatment of metabolic syndromeImplementation of case management to reduce cardiovascular disease risk in the Stanford and San Mateo Heart to Heart randomized controlled trial: study protocol and baseline characteristicsIncreased severity of tuberculosis in Guinea pigs with type 2 diabetes: a model of diabetes-tuberculosis comorbidityWhat is metabolic syndrome, and why are children getting it?Comparison of free serum oxylipin concentrations in hyper- vs. normolipidemic menHealth disparities in endocrine disorders: biological, clinical, and nonclinical factors--an Endocrine Society scientific statementLuteal phase dynamics of follicle-stimulating and luteinizing hormones in obese and normal weight womenNew measure of insulin sensitivity predicts cardiovascular disease better than HOMA estimated insulin resistanceAchieving secondary prevention low-density lipoprotein particle concentration goals using lipoprotein cholesterol-based dataThe "New Deadly Quartet" for cardiovascular disease in the 21st century: obesity, metabolic syndrome, inflammation and climate change: how does statin therapy fit into this equation?Triglyceride High-Density Lipoprotein Ratios Predict Glycemia-Lowering in Response to Insulin Sensitizing Drugs in Type 2 Diabetes: A Post Hoc Analysis of the BARI 2D.Change in metabolic syndrome parameters with antipsychotic treatment in the CATIE Schizophrenia Trial: prospective data from phase 1Utility of the modified ATP III defined metabolic syndrome and severe obesity as predictors of insulin resistance in overweight children and adolescents: a cross-sectional studyPerturbation of lipids and glucose metabolism associated with previous 2,4-D exposure: a cross-sectional study of NHANES III data, 1988-1994Using pre-existing microarray datasets to increase experimental power: application to insulin resistance.Effects of apolipoprotein A5 haplotypes on the ratio of triglyceride to high-density lipoprotein cholesterol and the risk for metabolic syndrome in Koreans.The metabolic syndromeSurrogate index for insulin sensitivity composed of factors not using glucose and insulin in Japanese patients with diabetesIdentification of cardiometabolic risk among collegiate football players.Fasting triglycerides as a predictor of incident diabetes, insulin resistance and β-cell function in a Canadian First Nation.The impact of obstructive sleep apnea on metabolic and inflammatory markers in consecutive patients with metabolic syndrome.Plasma lactate and diabetes risk in 8045 participants of the atherosclerosis risk in communities studyInsulin resistance in adolescents with type 1 diabetes and its relationship to cardiovascular function.Statins in the treatment of polycystic ovary syndrome.Age-modification of lipoprotein, lipid, and lipoprotein ratio-associated risk for coronary artery calcium (from the Multi-Ethnic Study of Atherosclerosis [MESA]).Insulin resistance, diabetes mellitus and thyroid dysfunction in patients with palmoplantar pustulosis: a case-controlled study.Prevalence and treatment of atherogenic dyslipidemia in the primary prevention of cardiovascular disease in Europe: EURIKA, a cross-sectional observational study.Use of waist circumference to predict insulin resistance: retrospective study.Tailoring dietary approaches for weight loss.Relationship between serum concentrations of persistent organic pollutants and the prevalence of metabolic syndrome among non-diabetic adults: results from the National Health and Nutrition Examination Survey 1999-2002.The TG/HDL-C Ratio Might Be a Surrogate for Insulin Resistance in Chinese Nonobese Women.Waist circumference, not the metabolic syndrome, predicts glucose deterioration in type 2 diabetes.HLA alleles may serve as a tool to discriminate atypical type 2 diabetic patients.Lipid ratios and appropriate cut off values for prediction of diabetes: a cohort of Iranian men and women.Plasma levels of high-density lipoprotein cholesterol and outcomes in pulmonary arterial hypertension.Size at birth, morning cortisol and cardiometabolic risk markers in healthy Indian children.Effect of Breathwalk on body composition, metabolic and mood state in chronic hepatitis C patients with insulin resistance syndrome.
P2860
Q24532776-3799438F-E6F8-4FDB-8658-25FAC4D5B94AQ24801508-A232C268-5F55-4F45-8D4F-4983AAFF1346Q28079121-9FF86049-0B7F-46DD-9720-367153B02F19Q28168652-C8DA557A-27C3-4F07-BCD5-1D1E39FC1A8CQ28200558-2BC7C3B1-8B8B-47C9-AFF0-690E3C35B7FBQ28383076-A7C18A29-0887-413D-8622-CF359EF2DCDCQ28385817-3306E8D7-A640-43DF-A810-54B999B3ED68Q28387829-3A819727-641B-438A-9B62-6EA96883FE4FQ28388174-71255FEF-E296-47B5-93AA-2DE60612055EQ28391267-595C6CDD-B2BE-445E-8CC7-1A965DD5E7A8Q28533926-F85BBE5E-9221-4ED9-9F0B-3468CDDD8EC0Q28730849-4D5703F4-9C74-4128-8D11-A41F30D49203Q30356827-6A90E1C8-7469-443C-98EA-5EA25C5CA3EEQ30384663-0A3B8D02-C9DC-4857-93A6-AB425D32BFA3Q31145823-13C8E5C1-9EA1-4F15-8D82-9B1EA98D5BE6Q33273785-037158B6-B442-4D64-BBE7-4E2D220769E4Q33534863-1C40488A-89CE-4676-8C54-196E4257FD23Q33548788-BB3689C5-305F-4F38-8EA2-D03203F45A67Q33559552-D327EB33-557C-435E-9013-6DBC8A3019E8Q33569142-BF8469D8-3648-4BE4-95B9-F5856C16B91DQ33588313-09812560-BD09-46D5-9DB7-D90365A7B9BCQ33600203-0462905C-89D7-42F1-ACE9-7A439261082DQ33604239-422EC7B3-C554-4228-A0DF-1C4C6A855625Q33658835-5FB71ABE-8E34-4BB6-A984-4A0B577024DEQ33668158-D35DA2D5-111B-4E39-A2DA-095F79C0B7F2Q33736145-84E80820-454B-478D-954B-3387401B0455Q33789151-54C73BCE-E8A1-4673-9F06-3367AABFC341Q33794539-575A2AA5-BA04-49F0-9405-E085213238F1Q33799964-E0B11A84-E804-4CBE-9060-5050A932D3EEQ33808302-980D3344-8252-4507-A5D9-8E150FC69455Q33941079-418D1FC7-9F37-42A8-B8E1-A45533F10D5CQ33942564-2C023BD0-D21D-4096-A06C-E3023F8F776DQ34005096-F8390BB0-08DE-4370-A68B-37364960EC13Q34033529-E9C214BC-7B85-4BF4-BA8F-2B83F46BFA72Q34040213-3DACD725-D8F7-4819-AE34-FCD3E695404AQ34068456-AE7C3038-15AF-460C-9B91-DC3AD73D4105Q34105262-18E6A2E9-F999-4760-8FC6-84926BAFFBE4Q34118474-4C1207CB-77C2-4EEF-A482-3AF259AB3A3AQ34178569-66463B1C-75FD-41AA-A06D-261868EECA78Q34225234-A78D7097-58AB-493E-AD97-F57CBF15CC35
P2860
Use of metabolic markers to identify overweight individuals who are insulin resistant.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Use of metabolic markers to identify overweight individuals who are insulin resistant.
@en
Use of metabolic markers to identify overweight individuals who are insulin resistant.
@nl
type
label
Use of metabolic markers to identify overweight individuals who are insulin resistant.
@en
Use of metabolic markers to identify overweight individuals who are insulin resistant.
@nl
prefLabel
Use of metabolic markers to identify overweight individuals who are insulin resistant.
@en
Use of metabolic markers to identify overweight individuals who are insulin resistant.
@nl
P2093
P1476
Use of metabolic markers to identify overweight individuals who are insulin resistant.
@en
P2093
Fahim Abbasi
Karen Cheal
Tracey McLaughlin
P304
P356
10.7326/0003-4819-139-10-200311180-00007
P407
P577
2003-11-01T00:00:00Z